Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 10Observational 2

Sponsor

Cancer Type

Endocrine 2Head & Neck 1

Conditions

Thyroid cancer, Hurthle cell 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Carcinoma, Neuroendocrine 1Adenocarcinoma, Follicular 1

Interventions

Blood Specimen Collection 56Surveys and Questionnaires 51Specimen Handling 30Observation 18Radiotherapy 15Interviews as Topic 12Magnetic Resonance Spectroscopy 11Surgical Procedures, Operative 10Data Collection 10Watchful Waiting 9Drug Therapy 9Biopsy 9darolutamide 8Tomography, X-Ray Computed 8palbociclib 7Standard of Care 7Magnetic Resonance Imaging 7Immune Checkpoint Inhibitors 7ribociclib 6Patient Reported Outcome Measures 6Bevacizumab 6trastuzumab deruxtecan 5Ultrasonography 5Restraint, Physical 5Radiofrequency Ablation 5Mastectomy, Segmental 5Mass Screening 5Genetic Testing 5Breath Tests 5enzalutamide 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × gallium Ga 68 dotatate × 90 days × Clear all
NCT00001160 2026-05-12

Studies on Tumors of the Thyroid

National Institutes of Health Clinical Center (CC)

Recruiting
2,500 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenocarcinoma, Follicular

NCT04069299 2026-03-31

Use of 68Ga-dotatate PET Scan in Neuroendocrine Carcinoma of the GI Tract

H. Lee Moffitt Cancer Center and Research Institute

Completed
30 enrolled
Endocrine

Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon âš¡